Evaluation of the prehospital administration of tranexamic acid for injured patients: a state-wide observational study with sex and age-disaggregated analysis.

IF 2.7 3区 医学 Q1 EMERGENCY MEDICINE Emergency Medicine Journal Pub Date : 2024-07-22 DOI:10.1136/emermed-2023-213806
Camille Girardello, Pierre-Nicolas Carron, Fabrice Dami, Vincent Darioli, Mathieu Pasquier, François-Xavier Ageron
{"title":"Evaluation of the prehospital administration of tranexamic acid for injured patients: a state-wide observational study with sex and age-disaggregated analysis.","authors":"Camille Girardello, Pierre-Nicolas Carron, Fabrice Dami, Vincent Darioli, Mathieu Pasquier, François-Xavier Ageron","doi":"10.1136/emermed-2023-213806","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Tranexamic acid (TXA) decreases mortality in injured patients and should be administered as soon as possible. Despite international guidelines recommending TXA in the prehospital setting, its use remains low. The aim of this study was to assess the prehospital administration of TXA for injured patients in a Swiss region.</p><p><strong>Methods: </strong>We conducted a retrospective observational study in Switzerland between 2018 and 2021. Inclusion criteria were injured patients ≥18 years for whom an ambulance or helicopter was dispatched. The exclusion criterion was minor injury defined by a National Advisory Committee for Aeronautics score <3. The primary outcome was the proportion of patients treated with TXA according to guidelines. The European guidelines were represented by the risk of death from bleeding (calculated retrospectively using the Bleeding Audit for Trauma and Triage (BATT) score). Factors impacting the likelihood of receiving TXA were assessed by multivariate analysis.</p><p><strong>Results: </strong>Of 13 944 patients included in the study, 2401 (17.2%) were considered at risk of death from bleeding. Among these, 257 (11%) received prehospital TXA. This represented 38% of those meeting US guidelines. For European guidelines, the treatment rate increased with the risk of death from bleeding: 6% (95% CI 4.4% to 7.0%) for low risk (BATT score 3-4); 13% (95% CI 11.1% to 15.9%) for intermediate risk (BATT score 5-7); and 21% (95% CI 17.6% to 25.6%) for high risk (BATT score ≥8) (p<0.01). Women and the elderly were treated less often than men and younger patients, irrespective of the risk of death from bleeding and the mechanism of injury.</p><p><strong>Conclusion: </strong>The proportion of injured patients receiving TXA in the prehospital setting of the State of Vaud in Switzerland was low, with even lower rates for women and older patients. The reasons for this undertreatment are probably multifactorial and would require specific studies to clarify and correct them.</p>","PeriodicalId":11532,"journal":{"name":"Emergency Medicine Journal","volume":" ","pages":"452-458"},"PeriodicalIF":2.7000,"publicationDate":"2024-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11287560/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Emergency Medicine Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/emermed-2023-213806","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"EMERGENCY MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Tranexamic acid (TXA) decreases mortality in injured patients and should be administered as soon as possible. Despite international guidelines recommending TXA in the prehospital setting, its use remains low. The aim of this study was to assess the prehospital administration of TXA for injured patients in a Swiss region.

Methods: We conducted a retrospective observational study in Switzerland between 2018 and 2021. Inclusion criteria were injured patients ≥18 years for whom an ambulance or helicopter was dispatched. The exclusion criterion was minor injury defined by a National Advisory Committee for Aeronautics score <3. The primary outcome was the proportion of patients treated with TXA according to guidelines. The European guidelines were represented by the risk of death from bleeding (calculated retrospectively using the Bleeding Audit for Trauma and Triage (BATT) score). Factors impacting the likelihood of receiving TXA were assessed by multivariate analysis.

Results: Of 13 944 patients included in the study, 2401 (17.2%) were considered at risk of death from bleeding. Among these, 257 (11%) received prehospital TXA. This represented 38% of those meeting US guidelines. For European guidelines, the treatment rate increased with the risk of death from bleeding: 6% (95% CI 4.4% to 7.0%) for low risk (BATT score 3-4); 13% (95% CI 11.1% to 15.9%) for intermediate risk (BATT score 5-7); and 21% (95% CI 17.6% to 25.6%) for high risk (BATT score ≥8) (p<0.01). Women and the elderly were treated less often than men and younger patients, irrespective of the risk of death from bleeding and the mechanism of injury.

Conclusion: The proportion of injured patients receiving TXA in the prehospital setting of the State of Vaud in Switzerland was low, with even lower rates for women and older patients. The reasons for this undertreatment are probably multifactorial and would require specific studies to clarify and correct them.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
对受伤患者院前使用氨甲环酸的评估:一项按性别和年龄分列的全州观察性研究。
背景:氨甲环酸(TXA)可降低受伤患者的死亡率,应尽快使用。尽管国际指南推荐在院前环境中使用氨甲环酸,但其使用率仍然很低。本研究旨在评估瑞士地区受伤患者院前使用氨甲环酸的情况:我们于 2018 年至 2021 年在瑞士开展了一项回顾性观察研究。纳入标准为年龄≥18 岁的受伤患者,并为其派遣了救护车或直升机。排除标准为国家航空咨询委员会评分界定的轻伤结果:在纳入研究的 13 944 名患者中,有 2401 人(17.2%)被认为有因出血而死亡的风险。其中 257 人(11%)接受了院前 TXA。这占符合美国指南的患者的 38%。就欧洲指南而言,治疗率随出血死亡风险的增加而增加:低风险(BATT 评分 3-4 分)为 6%(95% CI 4.4% 至 7.0%);中度风险(BATT 评分 5-7 分)为 13%(95% CI 11.1% 至 15.9%);高风险(BATT 评分≥8 分)为 21%(95% CI 17.6% 至 25.6%)(p 结论:接受院前 TXA 治疗的伤员比例较低:在瑞士沃州的院前环境中,受伤患者接受 TXA 治疗的比例很低,女性和老年患者的比例甚至更低。治疗不足的原因可能是多方面的,需要进行专门的研究来澄清和纠正。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Emergency Medicine Journal
Emergency Medicine Journal 医学-急救医学
CiteScore
4.40
自引率
6.50%
发文量
262
审稿时长
3-8 weeks
期刊介绍: The Emergency Medicine Journal is a leading international journal reporting developments and advances in emergency medicine and acute care. It has relevance to all specialties involved in the management of emergencies in the hospital and prehospital environment. Each issue contains editorials, reviews, original research, evidence based reviews, letters and more.
期刊最新文献
Conservative management of traumatic haemothoraces: a UK single-centre trauma unit retrospective audit. Emerging technology solutions to support national emergency workforce capacity-building initiatives: lessons from Ugandan policy and practice. Objective capillary refill to rapidly detect haemorrhage at the bedside. Olanzapine postinjection delirium/sedation syndrome after long-acting olanzapine depot injection presenting to the emergency department: practical guidelines for diagnosis and management. Best evidence topic report: are portable handheld fundus cameras effective in diagnosing diabetic retinopathy in emergency settings?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1